These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2583751)

  • 1. Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation.
    Chopra RK; Powers DC; Kendig NE; Adler WH; Nagel JE
    Immunol Invest; 1989 Oct; 18(8):961-73. PubMed ID: 2583751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro.
    Lai KN; Leung JC; Lai FM
    Pathology; 1991 Jul; 23(3):224-8. PubMed ID: 1838146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cells.
    Sahraoui Y; Allouche M; Ammar A; Spanakis E; Clemenceau C; Jasmin C; Perraki M; Varela-Millot C; Georgoulias V
    Leukemia; 1992 Oct; 6(10):1025-35. PubMed ID: 1405755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.
    Lai KN; Leung JC; Lai FM; Tam JS
    J Clin Immunol; 1989 Nov; 9(6):485-92. PubMed ID: 2630571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
    Mills GB; May C; McGill M; Fung M; Baker M; Sutherland R; Greene WC
    J Biol Chem; 1990 Feb; 265(6):3561-7. PubMed ID: 2303462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
    Reed JC; Alpers JD; Nowell PC; Hoover RG
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
    Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
    J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How interleukin-2 can affect human fibroblasts behaviour.
    Plaisance S; Alileche A; Han D; Rubinstein E; Sahraoui Y; Jasmin C; Azzarone B
    Pathol Res Pract; 1994 Oct; 190(9-10):942-9. PubMed ID: 7899144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogold labeling of the low-affinity (55 kd) IL2 receptor on the surface of IL2 receptor-bearing cultured cells and mitogen-activated peripheral blood lymphocytes.
    McGroarty RJ; Mills GB; de Harven E
    J Leukoc Biol; 1990 Sep; 48(3):213-9. PubMed ID: 2391447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression.
    Mills GB; Zhang N; May C; Hill M; Chung A
    Cancer Res; 1990 May; 50(10):3036-42. PubMed ID: 1692253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts.
    Chizzonite R; Truitt T; Desai BB; Nunes P; Podlaski FJ; Stern AS; Gately MK
    J Immunol; 1992 May; 148(10):3117-24. PubMed ID: 1578138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
    Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
    Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct demonstration that the monoclonal antibody AMT-13 and interleukin 2 bind to the same molecule.
    Osawa H; Diamantstein T
    Eur J Immunol; 1985 Mar; 15(3):299-301. PubMed ID: 2983999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptor.
    Chang MP; Castle SC; Norman DC
    Int J Immunopharmacol; 1992 Feb; 14(2):227-37. PubMed ID: 1624223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies.
    Duprez V; Ferrer M; Cornet V; Olive D; Dautry-Varsat A
    J Biol Chem; 1991 Jan; 266(3):1497-501. PubMed ID: 1988432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.